Global Patent Index - EP 1064388 A1

EP 1064388 A1 2001-01-03 - HUMAN CASB12 POLYPEPTIDE, A SERINE PROTEASE

Title (en)

HUMAN CASB12 POLYPEPTIDE, A SERINE PROTEASE

Title (de)

DAS MENSCHLICHE CASB12 POLYPEPTID IST EINE SERIN-PROTEASE

Title (fr)

POLYPEPTIDE CASB12 HUMAIN, UNE SERINGUE PROTEASE

Publication

EP 1064388 A1 (EN)

Application

EP 99916852 A

Priority

  • EP 9901894 W
  • GB 9806095 A

Abstract (en)

[origin: WO9949055A1] CASB12 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB12 polpypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particulary ovarian and colon cancers, autoimmune diseases, and related conditions.

IPC 1-7 (main, further and additional classification)

C12N 15/57; A61K 31/70; A61K 38/48; C07K 16/40; C12N 7/01; C12N 9/64; C12N 15/11; C12Q 1/68; G01N 33/68

IPC 8 full level (invention and additional information)

G01N 33/50 (2006.01); A61K 31/70 (2006.01); A61K 38/00 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); C07K 16/40 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 9/64 (2006.01); C12N 15/09 (2006.01); C12N 15/57 (2006.01); C12P 21/02 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/574 (2006.01); G01N 33/68 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

C12N 9/6424 (2013.01); A61K 39/00 (2013.01); A61K 2039/51 (2013.01); C12N 2799/021 (2013.01)

Citation (search report)

See references of WO 9949055A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9949055 A1 19990930; AU 3519299 A 19991018; CA 2323760 A1 19990930; EP 1064388 A1 20010103; GB 9806095 D0 19980520; JP 2002507425 A 20020312

INPADOC legal status


2005-03-16 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20040910

2004-06-16 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20040429

2003-01-15 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: GLAXOSMITHKLINE BIOLOGICALS S.A.

- Ref Legal Event Code: RAP1

2001-01-03 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20001020

2001-01-03 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE